IDBS Unveils Key Insights from Latest Survey on Lab Data Management in BioPharma

admin

IDBS, a leading global provider of cloud software for BioPharma companies, has shared compelling results from its latest survey into the current challenges and future priorities for lab data management in the Pharma/BioPharma industry. The recent survey gathered responses from 856 BioPharma professionals across the USA, UK, and Europe around their usage and experience with scientific lab data platforms with LIMS, LES, ELN, SDMS or CDS functionalities*.

Key Findings

Amongst the key findings, the IDBS platform was found to be used most often and had the highest level of satisfaction, with 77% of users expressing they were very satisfied, compared to 53% across all most used scientific lab data platforms.

Cited by around 30% of respondents, the most common challenges with their lab data platforms were limited scalability (34%), lack of flexibility (31%), poor integration with other tools (30%), complex user interfaces (29%), and data silos (26%). Data silos (6%) and complex user interface (6%) are less likely to be main challenges for those who mostly use an IDBS platform.

Looking to their future priorities, respondents cited enhancing data quality and integrity as their most popular goal for implementing a new scientific lab data platform (32%), with improving research efficiency as the next highest ranked goal (25%). Ensuring compliance with regulations and cost reduction, although important, were the least important goals.

Conclusion

Scott Weiss, VP of Product & Strategy at IDBS, commented, “Research insights like these are invaluable in helping us understand and address the evolving needs of the BioPharma sector. The survey results confirm that our focus on enhancing the unique pillars of our enterprise lab informatics platform, IDBS Polar, is well-aligned with industry demands. By continuing to develop a flexible, compliant workflow engine that creates unified, contextualized, and accessible experiment, product, and process data that is AI-ready, we are committed to meeting the needs of our customers now and into the future.”

For more information, visit the IDBS blog.

*Key:

LIMS – Laboratory Information Management System

LES – Laboratory Execution System

ELN – Electronic Laboratory Notebook

Next Post

Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers

Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide. The nordicPRO-C3™ biomarker is already validated in […]
thehealthco